The use of cannabinoids in veterinary medicine has been increasing exponentially recently and there is little information regarding the pharmacokinetics
Library Categories
CURATED RESEARCH LIBRARY
CATEGORY : Pharmacokinetics / Pharmacodynamics
Pharmacokinetics, Safety, and Synovial Fluid Concentrations of Single- and Multiple-Dose Oral Administration of 1 and 3 mg/kg Cannabidiol in Horses
Cannabidiol (CBD) products are widely marketed to horse owners, trainers, and veterinarians and are readily available to the consumer despite
Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
The therapeutic potential of cannabidiol (CBD), a non-psychtropic component of the Cannabis sativa plant, is substantiated more and more. We
Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs
Objective: To determine the safety and pharmacokinetics of various doses of plant-derived cannabidiol (CBD) versus placebo following repeated oral administration.
Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles
Cannabinoids hold promise for treating health problems related to inflammation and chronic pain in dogs, in particular cannabidiol (CBD), and
Pharmacokinetics of cannabidiol, cannabidiolic acid, delta-9-tetrahydrocannabinolic acid and related metabolites in canine serum after dosing with three oral forms of hemp extract
Cannabidiol (CBD)-rich hemp extract use is increasing in veterinary medicine with little examination of serum cannabinoids. Many products contain small
The interplay between first-pass effect and lymphatic absorption of cannabidiol and its implications for cannabidiol oral formulations
For highly lipophilic drugs, passage into the intestinal lymphatic system rather than the portal vein following oral administration may represent
Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy
Background: To date, an increasing number of pet owners, especially in the USA, are using cannabis-derived products containing generally delta
Pharmacokinetic and safety evaluation of various oral doses of a novel 1:20 THC:CBD Cannabis herbal extract in dogs
Objective: To determine the pharmacokinetics (PK) and safety of various oral doses of a Cannabis herbal extract (CHE) containing a
Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
The use of CBD-rich hemp products is becoming popular among pet owners with no long-term safety data related to consumption
© 2025 · Veterinary Cannabis Society